A detailed history of Advisors Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 40,932 shares of LLY stock, worth $32.6 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
40,932
Previous 47,854 14.46%
Holding current value
$32.6 Million
Previous $43.3 Million 16.3%
% of portfolio
0.69%
Previous 0.87%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $5.34 Million - $6.65 Million
-6,922 Reduced 14.46%
40,932 $36.3 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $7.98 Million - $10 Million
-11,009 Reduced 18.7%
47,854 $43.3 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $5.11 Million - $6.84 Million
-8,636 Reduced 12.79%
58,863 $45.8 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $3.95 Million - $4.65 Million
-7,515 Reduced 10.02%
67,499 $39.3 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $1.36 Million - $1.82 Million
-3,875 Reduced 4.91%
75,014 $35.2 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $254,405 - $298,787
819 Added 1.05%
78,889 $27.1 Million
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $58,999 - $67,236
-199 Reduced 0.22%
89,156 $28.8 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $1.96 Million - $2.31 Million
-7,049 Reduced 7.31%
89,355 $29 Million
Q1 2022

May 17, 2022

SELL
$234.69 - $291.66 $1.12 Million - $1.39 Million
-4,771 Reduced 4.72%
96,404 $27.6 Million
Q4 2021

Feb 15, 2022

BUY
$224.85 - $279.04 $206,862 - $256,716
920 Added 0.92%
101,175 $27.9 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $24,819 - $30,543
-112 Reduced 0.11%
100,255 $23.2 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $1.24 Million - $1.6 Million
-6,872 Reduced 6.41%
100,367 $23 Million
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $1.33 Million - $1.72 Million
8,077 Added 8.15%
107,239 $20 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $872,255 - $1.15 Million
6,686 Added 7.23%
99,162 $16.7 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $118,876 - $137,502
-813 Reduced 0.87%
92,476 $13.7 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $602,294 - $724,854
4,415 Added 4.97%
93,289 $15.3 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $644,060 - $797,163
5,410 Added 6.48%
88,874 $12.3 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $755,389 - $935,617
7,065 Added 9.25%
83,464 $12.6 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.31 Million - $1.42 Million
12,264 Added 19.12%
76,399 $8.54 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $4.38 Million - $5.11 Million
-39,508 Reduced 38.12%
64,135 $7.11 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $400,382 - $471,278
-3,597 Reduced 3.35%
103,643 $13.4 Million
Q4 2018

Jan 31, 2019

BUY
$105.9 - $118.64 $1.35 Million - $1.51 Million
12,712 Added 13.45%
107,240 $12.4 Million
Q3 2018

Nov 15, 2018

SELL
$85.86 - $107.31 $39,581 - $49,469
-461 Reduced 0.49%
94,528 $10.1 Million
Q2 2018

Aug 22, 2018

BUY
$75.7 - $86.88 $4.26 Million - $4.89 Million
56,295 Added 145.49%
94,989 $8.11 Million
Q2 2018

Aug 15, 2018

SELL
$75.7 - $86.88 $5.9 Million - $6.77 Million
-77,937 Reduced 66.82%
38,694 $8.11 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $592,789 - $699,748
-7,988 Reduced 6.41%
116,631 $8.99 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $547,359 - $587,105
-6,680 Reduced 5.09%
124,619 $10.5 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $10.1 Million - $11.2 Million
131,299
131,299 $11.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.